Sample Brief
₩0.3M ~ ₩1M
Preview / scope check
- 1-page scope preview
- Lane recommendation
- Owner introduction
Brown Biotech · System of Intelligence
One brief,one owner, one next action.
Start with a paid brief — a continuous reasoning layer over PubMed, ClinicalTrials, ChEMBL, and GEO. Agent halves the work; the other half is biology judgment. One owner closes it.
Now wired to Boltz-2 (protein design + cofold) and benchmarked against Phylo's DrugDiscoveryBench — see why teams pick us.
Inspectable workflowHuman review requiredDecision-grade handoff
Paid brief · routing preview
One paid brief. Three lanes.
Every request enters the same harness and exits with a route, an owner, and a handoff.
peptide-service
PrimaryBrief → quote → execution
biostatx
Statistics for evidence
genox-site
Discovery & partner path
PubMedClinicalTrialsChEMBLGEO
High-stakes decisions route through human review. The harness can change; the owner does not.
0
Service lanes
Paid brief → retainer
0h
Response target
Inbound triage SLA
0
Evidence stacks
PubMed · ChEMBL · CT.gov · GEO
0%
Human approval
On high-stakes routes
Ready from day one
Brief first. Proof next. Clear handoff every time.
Brown Biotech Inc. turns inquiries into a small number of decision-ready lanes. The site, the intake, and the Notion hub all use the same words so the company feels like one system instead of separate pages.
9+
Active service lanes
Paid brief → specialty → strategic upgrade
24h
Brief response target
Route + owner assigned
4
Human approval gates
High-stakes decisions routed
System of Intelligence
One harness, four stages.
Brown Biotech runs a continuous reasoning layer over public data, then hands every output to one owner for one decision. The model can change; the harness does not.
Stage 01
Source
PubMed · ClinicalTrials · ChEMBL · GEO — 28 journals, 27 queries, 5 disease axes.
Continuous reasoning layer
Stage 02
Reason
AI-assisted analysis with LLM-as-router. Every output carries a route, an owner, and a fit score.
Visible harness, swappable model
Stage 03
Brief
A scoped, citation-anchored memo. Paid brief, project, or retainer — never an open-ended chat.
Decision-grade handoff
Stage 04
Review
High-stakes decisions route through human approval. Notion receipt + shareable markdown for partners.
Human gate respected
Live sourcesPubMedClinicalTrials.govChEMBLGEOOpenAlexEurope PMC
Why Brown Biotech
Agent halves the work. The other half is biology judgment.
Tool layers run the loop. Model layers pick the token. Our layer is what sits between them — the procedure, the source map, and the human reviewer that turns an agent into a decision. That's what we sell.
“Handed a human-written playbook, the agent passed 76 of 82 — over 90%. The difference is human expertise. Agents handle a single query or calculation fine, but they lose the thread on long workflows.”
Tool layer
Boltz · Biomni · Claude Science
Specialized biology models and integrated agent environments. They run the loop. They close the execution bottleneck (in silico co-fold, design, score). What they don't ship: the scientist's procedures for this molecule, this disease, this program.
Model layer
Frontier LLMs
GPT-5.5, Gemini 3.5, Opus 4.8 — DrugDiscoveryBench showed the top three within 5 points of each other. The model matters less than the procedure you give it.
Reasoning layer · ours
Brown Biotech
A continuous reasoning layer over PubMed, ClinicalTrials, ChEMBL, GEO, and your proprietary data — plus a human reviewer for every high-stakes brief. The model can change; the harness does not.
Procedural playbooks
Scientist-authored procedures — what to hold fixed, what to vary, which tool to trust on this instance. Handed to the agent, accuracy jumps above 90%.
Multi-source triangulation
PubMed + ChEMBL + ClinicalTrials + GEO + your internal data. One owner synthesizes; no orphan claims.
Decision-grade handoff
Every brief exits with a route, an owner, and an action — never an open-ended chat. High-stakes items go through human review.
Service lanes
Three primary lanes. Six more when you need them.
Each lane is a clear entry point with one owner, a fixed deliverable, and a visible next step. Paid brief is the default; project, specialty, and strategic tiers are reserved for scoped work.
Primary
peptide-service
The default entry point for peptide work. Brief first, quote second, execution after scope is clear.
Open laneSupporting
biostatx
Biostatistics and reporting for teams that need a cleaner decision path from raw data to evidence.
Open laneSupporting
genox-site
Discovery and genomics-facing support for scoping, framing, and partner conversations.
Open laneSpecialty
ai-drug-discovery
FPembed molecular reasoning — decision-scored candidates, not similarity lists.
Open laneSpecialty
research-intelligence
TrueSkill-ranked preprint tournament. PRISMA-RAISE compliant briefs with qualitative reasoning layer.
Open laneProject lane
strict-omics
Audit-grade transcriptomics pipelines. LLM proposes, deterministic gates decide.
Open lanearp-engine
FlagshipThe reasoning layer every paid brief runs on. System of Intelligence, with human approval gates.
business-pipeline
Strategic upgradeThe company pipeline itself, packaged as a reusable workflow with review gate.
Offer ladder
A clearer path from sample brief to retainer.
Keep the entry point small, then expand only when the brief, the owner, and the next action are clear.
Paid Brief
₩2M ~ ₩8M
Decision-ready research doc
- PubMed + ClinicalTrials + ChEMBL + GEO scan
- Decision-scored candidate set
- Human review gate before sign-off
- Notion handoff with route + owner
Project
₩8M ~ ₩30M+
Scoped analysis + execution
- Audit-grade pipeline
- Milestone-gated execution
- Co-authored deliverable
Retainer
₩3M ~ ₩15M+/mo
Monthly research / ops support
- Standing owner assignment
- Weekly cadence
- Priority intake routing
Proof and partner motion
Make the proof visible. Keep the partner path clean.
Brown Biotech shows enough research proof to build trust, enough public signal to stay visible, and a clear route for serious partner interest. If someone wants to collaborate, the first move is a brief.
Research proof
Scoped memos, citations, and decision-ready summaries that make the work easier to trust.
Brief first
Publications
Selected outputs stay public so partners can see the reasoning, not just the branding.
Evidence-led
Community
Useful updates, discussions, and reading notes keep the ecosystem warm without noise.
Signal-rich
Selected publications
Short outputs that prove the work.
Publish just enough to show the reasoning, the evidence, and the decision path. Each item should support a paid brief or a partner conversation.
Research brief
Scoped summary with citations, evidence map, and a recommendation you can act on.
Case note
A compact proof note with outcome, methods used, and what made the difference.
Methods note
Reusable analysis workflow or statistical approach you can apply to your next project.
Partner update
A focused signal brief that opens the next serious conversation with a clear ask.
Partner funnel
Partner-ready, not open-ended.
If someone wants to collaborate, advise, or buy, the first move should be a brief. That keeps the conversation clear and the work easier to deliver.
- 01qualify the signal
- 02route into the right lane
- 03assign one owner
- 04keep human approval where needed
Delegate the work
Own the decisions, not the busy work.
A simple process designed for fast handoff, transparent expectations, and usable outputs. We keep the loop narrow so the team can focus on the next useful action.
01
Scope
Clarify the need, audience, constraints, and the outcome you want before any work begins.
02
Route
Assign the lane, name the owner, and confirm the first milestone. You see the route, not just the result.
03
Deliver
Hand over a structured output, a practical recommendation, and one clear next step.
How we work
Why teams pick Brown Biotech.
The operating model stays narrow, visible, and reusable so the market sees one company, one workflow, and one next step. The harness improves; the vocabulary does not.
One lane at a time
The primary offer stays visible, so the work starts in the right place and the next step is always obvious.
AI-first, human-controlled
AI accelerates scope and analysis; high-stakes decisions stay with the human reviewer.
One source of truth
Website, intake, and Notion all share the same nouns, states, and routing rules.
Decision-ready outputs
Every request ends in a brief, a route, or a clear handoff — never an open-ended chat.
Visible proof
Research notes, publications, and partner signals are surfaced, not hidden behind marketing copy.
Reusable operating system
The same harness supports service work, partner funnel work, and operator review without new vocabulary.
Start with a brief
Request a brief
Need a paid brief, spec-driven pipeline support, or discovery scoping help? Send a note and we'll map the route, owner, and next step. If the fit is weak, we'll say so and route it cleanly.
Contact Information
We respond to all inquiries within 24 hours. For urgent matters, please call directly. Initial messages are handled with discretion.